Change rates and prevalence of a dichotomous variable: Simulations and applications

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Brinks, Ralph ^a   Landwehr, Sandra ^a,b  

^a LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC DISEASE; DEMENTIA; DICHOTOMOUS VARIABLE; EGYPTIAN; GERMANY; HEALTH SURVEY; MATHEMATICAL COMPUTING; MATHEMATICAL VARIABLE; MENSTRUAL CYCLE; MORTALITY; PARTIAL DIFFERENTIAL EQUATION; PREVALENCE; SIMULATION; SMOKING; HUMAN; PUBLIC HEALTH; STATISTICAL ANALYSIS; STATISTICAL MODEL;

DATA INTERPRETATION, STATISTICAL; HUMANS; MODELS, STATISTICAL; PREVALENCE; PUBLIC HEALTH;

EID: 84924187711     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118955     Document Type: Article

References (26)

1. Keeling MJ, Rohani P. Modeling Infectious Diseases. Princeton: Princeton University Press; 2008.
2. Schenzle D. An age-structured model of pre- and post-vaccination measles transmission. J Math Appl Med Biol 1984; 1:169-191. PMID: 6600102
3. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. Hoboken, NJ: John Wiley & Sons; 2002.
4. Fix E, Neyman J. A simple stochastic model of recovery, relapse, death and loss of patients. Hum Biol 1951; 23(3): 205-241. PMID: 14880165
5. Keiding N. Age-specific incidence and prevalence: a statistical perspective. J Roy Stat Soc A 1991; 154:371-412.
6. Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT, et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ, 2007; 334(7588):299. PMID: 17237299
7. Brinks R, Tamayo T, Kowall B, RathmannW. Prevalence of type 2 diabetes in Germany in 2040: Estimates from an epidemiological model. Eur J Epidemiol 2012; 27(10):791-797. doi: 10.1007/s10654-012-9726-2 PMID: 22878939
8. Waldeyer R, Brinks R, Rathmann W, Giani G, Icks A. Projection of the burden of type 2 diabetes mellitus in Germany: a demographic modelling approach to estimate the direct medical excess costs from 2010 to 2040. Diabet Med 2013; 30(8): 999-1008. doi: 10.1111/dme.12177 PMID: 23506452
9. Brinks R, Landwehr S, Icks A, Koch M, Giani G. Deriving age-specific incidence from prevalence with an ordinary differential equation. Stat Med 2013; 32(12): 2070-2078. doi: 10.1002/sim.5651 PMID: 23034867
10. Murray CJL, Lopez AD. Global and regional descriptive epidemiology of disability: incidence, prevalence, health expectancies and years lived with disability. In Murray CJL, Lopez AD, editors. The Global Burden of Disease. Boston: Harvard School of Public Health; 1996. pp. 201-246.
11. Federal Statistical Office of Germany. Mortality in Germany [cited 15 November 2013] Available: http://www.destatis.de
12. Ziegler U, Doblhammer G. Prävalenz und Inzidenz von Demenz in Deutschland [Prevalence and incidence of dementia in Germany]. Gesundheitswesen 2009; 71(5): 281-290. doi: 10.1055/s-0028-1119384 PMID: 19288422
13. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: Competing risks and multi-state models, Stat Med 2007; 26:2389-2430. PMID: 17031868
14. Schulze A, Lampert T. Bundes-Gesundheitssurvey: Soziale Unterschiede im Rauchverhalten und in der Passivbelastung in Deutschland [Social discrepancies of smoking behavior and passive smoking in Germany]. Berlin: Robert Koch-Institute Health Report 2006
15. Measure DHS (Demographic and Health Surveys) [cited 15 November] Available: http://measuredhs.com
16. ICF International: Demographic and Health Surveys EGIR01FL, EGIR21FL, EGIR33FL, EGIR41FL, EGIR4AFL, EGIR51FL, EGIR5AFL [Datasets]. Calverton, MD: ICF International [Distributor], 2013.
17. Kirkwood BR, Sterne JAC. Essential Medical Statistics. 2nd ed. Malden, MA: Blackwell 2003.
18. John U, Hanke M. Tabakrauch-attributable Mortalität in den deutschen Bundesländern [Tobacco smoking attributable mortality in German Federal States]. Gesundheitswesen 2001; 63(6):363-369. PMID: 11467218
19. Neubauer S, Welte R, Beiche A, Koenig HH, Buesch K, Leidl R. Mortality, morbidity and costs attributable to smoking in Germany: update and a 10-year comparison, Tob Control 2006; 15(6): 464-471. PMID: 17130376
20. Thun MJ, Carter BD, Feskanich D, Freedman ND, Prentice R, Lopez AD, et al. 50-year trends in smoking-related mortality in the United States. N Engl J Med 2013; 368(4): 351-364 doi: 10.1056/NEJMsa1211127 PMID: 23343064
21. UNAIDS Middle East and North Africa Regional Report on AIDS, 2011 [cited 15 November 2013] Available: http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2011/JC2257-UNAIDS-MENA-report-2011-en.pdf
22. Carstensen B, Kristensen JK, Ottosen P, Borch-Johnsen K. The Danish National Diabetes Register: trends in incidence, prevalence and mortality. Diabetologia 2008; 51: 2187-2196 doi: 10.1007/s00125-008-1156-z PMID: 18815769
23. Murray CJ, Lopez AD. Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of Disease Study. Lancet 1997; 349(9062): 1347-1352. PMID: 9149696
24. Vos T, Flaxman AD. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380 (9859): 2163-96 doi: 10.1016/S0140-6736(12)61729-2 PMID: 23245607
25. Bell BM, Flaxman AD. A Statistical Model and Estimation of Disease Rates as Functions of Age and Time. Siam Journal on Scientific Computing: Computational Methods in Science and Engineering, 35(2), B511-B528.
26. Software accessed: http://github.com/aflaxman/dismod-pde